Stem Cell Therapy for Avascular Necrosis: Treatment and Recovery Time

Avascular necrosis develops when the blood supply to a section of bone is disrupted, causing bone tissue to weaken and eventually collapse if left untreated. Stem cell therapy for avascular necrosis has drawn growing interest as a way to support bone healing before that collapse happens, particularly when combined with a procedure called core decompression. This article explains how the condition develops, what this regenerative approach actually involves, what current research shows about outcomes, and what a realistic recovery timeline looks like.

Understanding the condition early matters because avascular necrosis, also called osteonecrosis, tends to progress in stages, and treatment is far more effective before the bone structure collapses.

What Is Avascular Necrosis and Why Blood Supply Matters

Bone is living tissue that depends on a continuous blood supply to stay healthy and repair itself. When that supply is interrupted, whether from trauma, high-dose corticosteroid use, excessive alcohol use, or conditions affecting blood clotting, the bone cells in the affected area begin to die. This is most common in the hip, specifically the femoral head, but it can also affect the knee, shoulder, and other joints.

Avascular necrosis is commonly staged using the Ficat and Arlet classification, which tracks progression from an early stage with no visible changes on X-ray through to end-stage disease marked by femoral head collapse and joint space narrowing (Matthews et al., StatPearls). Risk factors include chemotherapy or radiation exposure, hip trauma, long-term steroid use, sickle cell disease, and heavy alcohol use, and because early-stage disease often shows no findings on physical exam, it can progress silently before symptoms appear.

Recognizing Avascular Necrosis Symptoms

Avascular necrosis symptoms often develop gradually and can be easy to dismiss early on. According to Mayo Clinic, many people have no symptoms in the earliest stages, and pain typically appears first with weight-bearing activity before eventually occurring at rest as the condition advances (Mayo Clinic).

When the hip is affected, pain commonly centers on the groin, thigh, or buttock and may worsen with standing or walking. In the knee, pain tends to appear during weight-bearing movement, while shoulder involvement can produce a deeper, radiating ache. Because these symptoms overlap with other joint conditions such as osteoarthritis or tendinopathy, imaging is usually needed to confirm the diagnosis. MRI is considered the most sensitive tool for detecting avascular necrosis, especially in its earliest stages before changes are visible on a standard X-ray.

How This Regenerative Approach Works

This regenerative approach is most often delivered alongside core decompression, in which a surgeon drills into the affected bone to relieve internal pressure and create a channel for new blood vessel growth. Concentrated bone marrow aspirate, which contains mesenchymal stem cells, is then introduced into that channel to support new bone formation and vascular regrowth in the damaged area.

Mesenchymal stem cells can differentiate into bone-forming cells and may help stimulate repair signaling in a region where blood flow has already been compromised. This approach is generally reserved for earlier-stage disease, before significant structural collapse, since the goal is to preserve the native joint rather than reverse damage that has already progressed to collapse.

What the Research Shows: Stem Cells Plus Core Decompression vs. Core Decompression Alone

Several systematic reviews have compared core decompression alone with core decompression combined with stem cell augmentation. A 2023 meta-analysis pooling data from more than 900 patients and over 1,200 hips found that adding stem cell therapy was associated with meaningfully better outcomes at 2 to 5 year follow-up: 30.5% of hips in the stem cell group experienced femoral head collapse compared with 44.4% in the core-decompression-only group, and 15.2% required conversion to total hip arthroplasty compared with 29.4% in the control group (Li et al., Journal of Orthopaedic Surgery and Research, 2023). Harris Hip Score improvements, a standard measure of hip pain and function, were also significantly greater in the combined-treatment group across most included studies.

A more recent 2025 meta-analysis and meta-regression of randomized controlled trials reached a similar conclusion, reporting that bone marrow stem cell therapy is associated with reduced femoral head collapse risk, reduced conversion to total hip arthroplasty, and improved hip function and pain scores, with the strongest benefit seen when treatment starts at an early disease stage and no serious treatment-related complications documented across long-term follow-up (Novriansyah et al., PLOS ONE, 2025). This same review flagged that stem cell harvesting and dosing protocols vary across studies, which is one reason outcomes should be discussed individually with a treating physician rather than assumed to be uniform.

Experience the
power of millions
of cells working
to regenerate you

Get Started

Avascular Necrosis Surgery Recovery Time

Recovery after core decompression with stem cell augmentation generally follows a staged weight-bearing protocol. One comparative study of the combined procedure reported that patients were kept non-weight-bearing for approximately the first 3 weeks after surgery, followed by partial weight bearing from weeks 3 to 6, with full weight bearing typically introduced after 6 weeks (Ulusoy et al., Journal of Orthopaedic Surgery and Research, 2023). Formal outcome assessments in that study were conducted at 3 months, 6 months, 1 year, and 2 years, reflecting how gradually bone remodeling and symptom improvement tend to unfold.

Most patients can expect a period of crutch or walker use during the early weeks, with functional improvement continuing over several months rather than immediately after the procedure. Because recovery time depends on disease stage and individual healing response, a treating physician can provide a more specific timeline based on imaging and clinical progress.

Safety Considerations

Regenerative approaches for avascular necrosis generally show a favorable safety profile in the research above, but they are not appropriate for every stage of disease. Once significant femoral head collapse has occurred, core decompression and stem cell augmentation are less likely to preserve the joint, and joint replacement may become the more appropriate option. Underlying conditions that caused the avascular necrosis, such as corticosteroid dependence or clotting disorders, should also be addressed as part of a comprehensive treatment plan.

Frequently Asked Questions

How does stem cell therapy work for this condition?

It is a regenerative treatment, usually performed alongside core decompression, in which concentrated bone marrow stem cells are introduced into the affected bone to support new bone formation and blood vessel growth in the area damaged by reduced blood supply.

What are the earliest avascular necrosis symptoms?

Early avascular necrosis symptoms can include mild joint pain that worsens with weight-bearing activity, though many people have no noticeable symptoms at all in the earliest disease stage, which is part of why imaging is important for early detection.

Is stem cell therapy effective for avascular necrosis?

Research suggests that combining stem cell therapy with core decompression is associated with lower rates of femoral head collapse and joint replacement compared with core decompression alone, particularly when started before significant structural damage has occurred.

What is a typical avascular necrosis surgery recovery time?

Based on published surgical protocols, patients are generally non-weight-bearing for about 3 weeks, transition to partial weight bearing through week 6, and progress to full weight bearing afterward, with continued functional improvement over several months.

Can stem cell therapy reverse advanced avascular necrosis, and who is a candidate?

Current evidence suggests stem cell therapy is most effective in earlier disease stages before collapse occurs, and candidacy depends on disease stage, the joint involved, and overall health, which is why a clinical evaluation with imaging is necessary first.

Are there risks associated with this treatment?

Reviewed studies have not documented serious treatment-related complications such as infection or abnormal tissue growth over long-term follow-up, though individual risk should still be discussed with a treating physician.

stem-cell-therapy-for-avascular-necrosis

Talk to Ways2Well About Your Options

Avascular necrosis is easier to manage the earlier it is caught. Ways2Well’s stem cell therapy programs are built around personalized evaluation, and you can schedule a consultation to discuss your symptoms, imaging, and whether a regenerative approach fits your situation. Learn more about Ways2Well’s full range of regenerative and functional health services.

For related reading, see Ways2Well’s guides on stem cells vs. knee replacement and mesenchymal stem cells vs. hematopoietic stem cells.

Sources

Author: Ways2Well Editorial Team

Reviewed by: Scientific Advisory Board member